Lantern Pharma (NASDAQ: LTRN), a clinical-stage biotechnology company, is leveraging artificial intelligence and machine learning to redefine oncology drug development.…
Nevada’s Walker Lane area is becoming a prime target for mineral exploration Lahontan Gold is focused on becoming a strategic…
Despite the critical importance of rare earth element metals, the United States has long been dependent on imports to provide…
Clene (NASDAQ: CLNN) announced key regulatory developments following a Type C meeting with the FDA, where it received feedback on its…
NextPlat (NASDAQ: NXPL, NXPLW) released a shareholder letter from Interim CEO expressing confidence in the company’s future following the recent…
NGTF combines AI-powered robotics technology with strategic hotel acquisitions, expanding into new vision for next-generation hospitality solutions Recent executive appointments…
As artificial intelligence (“AI”) continues to revolutionize industries, the infrastructure supporting its growth has become increasingly reliant on copper due…
The company announced the groundbreaking of its Louisiana Strategic Metals Complex (“SMC”) in Alexandria. The Louisiana SMC is designed to…
Calidi Biotherapeutics (NYSE American: CLDI), a clinical-stage biotech company developing systemic oncolytic targeted immunotherapies, released a shareholder letter from CEO…
The new FDA voucher program aims to speed approval of drugs aligned with national health priorities. NRX-100, a preservative-free ketamine,…